Skip to content

Altimmune ALT Deferred Taxes

Deferred Taxes at other companies

Eli Lilly logo
Eli LillyLLY
$1.48B+277%
Merck & Co. logo
Merck & Co.MRK
-$315M-69.4%
PTC Therapeutics logo
PTC TherapeuticsPTCT
-$10K-600%
Ironwood Pharmaceuticals logo
Ironwood PharmaceuticalsIRWD
$19.2M+2,765%
Corcept Therapeutics logo
Corcept TherapeuticsCORT
-$13.11M+4.3%

Other financials

Income statement

See full
Revenue$26.0K+420%
Operating income-$24.2M-11.1%
Net income-$22.6M-15.3%
EPS (diluted)-$0.18+30.8%

Balance sheet

See full
Cash & equivalents$97.6M+98.7%
Total debt$34.8M+14,092%
Total equity$284.0M+99.8%
Total assets$335.6M+113%

Cash flow

See full
Operating cash flow-$20.9M-24.4%
CapEx$21.0K
Free cash flow-$21.0M

Valuation

See full
Market cap$558.14M-2.1%
Enterprise value$495.27M-5.0%
P/S13,613.2×-24,380×

Profitability

See full
Operating margin-230,461%-82,087pp
Net margin-214,861%-76,057pp
FCF margin-17,806.8%-110,030pp

Returns & leverage

See full
Return on equity-42.7%-8.7pp
Debt / equity0.1×+0.1×
Current ratio29.6×+13.7×

Where this comes from

Reported directly by Altimmune in its filing.

Tagged under the XBRL concept us-gaap:DeferredIncomeTaxExpenseBenefit.

The official record: Altimmune’s 10-Q, filed May 13, 2026, on SEC EDGAR. View the filing →

Ask your AI about Altimmune's deferred taxes.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Altimmune's deferred taxes?
Altimmune (ALT) reported deferred taxes of -$681K in Q1 2025.
What does deferred taxes mean?
Non-cash deferred tax expense or benefit representing the change in deferred tax assets/liabilities during the period.